Cost-Effectiveness and Budget Impact of a Novel Antithrombotic Drug Removal System to Reduce Bleeding Risk in Patients on Preoperative Ticagrelor Undergoing Cardiac Surgery

Figures

• 

  Fig. 1. A 1-year Markov model following patients from coronary artery bypass graft surgery (CABG) and postoperative care with and without the use of the DrugSorb-ATR device to reduce risk of moderate-massive bleeds

• 

  Fig. 2. Univariate sensitivity analyses, tornado diagram. Results: patients with < 1 day of washout (a); patients with 1–2 days of washout (b)

• 

  Fig. 3. Probabilistic sensitivity analyses, scatterplots. Results: patients with < 1 day of washout (a); patients with 1–2 days of washout (b)

• 

  Fig. 4. Probabilistic sensitivity analyses, cost-effectiveness acceptability curves. Results: patients with < 1 day of washout (a); patients with 1–2 days of washout (b)